Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
73.1M
-
Number of holders
-
168
-
Total 13F shares, excl. options
-
41.5M
-
Shares change
-
-8.19M
-
Total reported value, excl. options
-
$289M
-
Value change
-
-$56.7M
-
Put/Call ratio
-
1.23
-
Number of buys
-
83
-
Number of sells
-
-51
-
Price
-
$6.96
Significant Holders of Mind Medicine (MindMed) Inc. - Common Stock (MNMD) as of Q4 2024
204 filings reported holding MNMD - Mind Medicine (MindMed) Inc. - Common Stock as of Q4 2024.
Mind Medicine (MindMed) Inc. - Common Stock (MNMD) has 168 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.5M shares
of 73.1M outstanding shares and own 56.74% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (6.07M shares), COMMODORE CAPITAL LP (4.31M shares), Blackstone Inc. (3.59M shares), Driehaus Capital Management LLC (3.38M shares), Octagon Capital Advisors LP (3.02M shares), Deep Track Capital, LP (2.82M shares), MARSHALL WACE, LLP (2.5M shares), VANGUARD GROUP INC (1.91M shares), STATE STREET CORP (1.78M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.72M shares).
This table shows the top 168 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.